M4MM
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...
Earnings Season: Cannabis Operators Deliver a Different Kind of Q2 2026
LOS ANGELES – The Cannabis industry wraps up its second-quarter earnings, and the aggregate picture carries a theme that would have been harder to locate a few years ago. Operators are making money. Profitability, not ...
FLUENT Shareholders Approve All-Stock Acquisition by Vireo
TORONTO – FLUENT Corp. reported that holders of its common and proportionate voting shares approved the special resolution for an all-stock plan of arrangement with Vireo Growth Inc. at the annual general and special meeting ...
IRS Pushes Back on Cannabis Tax Refund Claims as the 280E Battle Enters a New Era
WASHINGTON, D.C.-The Cannabis industry's long-running battle with Section 280E has entered a pivotal new phase. For years, one of the greatest financial challenges facing state-licensed Cannabis businesses has not been competition or regulation—it has been ...
Organigram Highlights Early Sanity Results While Holding Canadian Market Lead
TORONTO – Three months after closing its largest international acquisition to date, Organigram Global Inc. has delivered the first combined business update covering Sanity Group's early performance alongside the company's ongoing Canadian market position. The ...
Colder BHO Extractions Yield Cleaner Cannabis Concentrates, Abstrax Study Finds
LOS ANGELES – Researchers at Abstrax Tech have found that colder extraction temperatures during butane hash oil (BHO) processing significantly reduce the carryover of plant-derived wax compounds into finished concentrates, without meaningfully affecting cannabinoid potency ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...
Earnings Season: Cannabis Operators Deliver a Different Kind of Q2 2026
LOS ANGELES – The Cannabis industry wraps up its second-quarter earnings, and the aggregate picture carries a theme that would have been harder to locate a few years ago. Operators are making money. Profitability, not ...
Trulieve Reports Q3 2025 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. disclosed third-quarter results showing revenue of $288 million, edging up 1% from the year-ago period but dipping 5% from the second quarter. The figures highlight a push toward tighter operations ...
Trulieve Redeems $368M in Notes, Signaling Debt Reduction Push
TALLAHASSEE – Trulieve Cannabis Corp. has announced its decision to redeem its entire $368 million portfolio of 8.0% senior secured notes, due in 2026. The company issued the redemption notice, setting an early payoff date ...
Jushi Holdings Reports Q3 2025 Financial Results
LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer ...
Compass Pathways Advances Psilocybin Therapy Timeline for Depression Treatment
LONDON & NEW YORK – Compass Pathways reported Q3 2025 financial results and signaled a faster path to market for its lead psilocybin-based therapy in treatment-resistant depression (TRD). The biotechnology firm now targets commercialization readiness ...
Missouri Trade Group Report Finds 96% of Tested Hemp Products Exceed THC Thresholds
KANSAS CITY – A new investigation by the Missouri Cannabis Trade Association (MoCannTrade) has concluded that nearly all hemp-derived products sold at unregulated retailers in the state contain illegal levels of THC, raising questions about ...
New Mexico Cannabis Market Edges Toward $2B in Total Sales
ALBUQUERQUE – New Mexico's Cannabis industry has recorded $1.9 billion in combined medical and adult-use sales since recreational legalization took effect in April 2022, according to the latest figures from the state’s Regulation and Licensing ...
Fairfax Bank Retreats from Servicing Cannabis Businesses
FAIRFAX – MainStreet Bancshares Inc., a community lender with $2.2 billion in assets, has shelved its Cannabis banking program just eight months after unveiling it as a growth driver. The decision, disclosed by CEO Jeff ...
Stiiizy Halts Sales at Catalyst Outlets as Leadership Clash Deepens
LOS ANGELES – Stiiizy, California's dominant Cannabis brand with a footprint in Arizona, Michigan, and Nevada, has stopped supplying its products to Catalyst Cannabis Co. stores, marking a sharp break in what was once a ...
Arizona Funds Nation’s First Whole-Mushroom Psilocybin Trial Targeting PTSD in Veterans & First Responders
PHOENIX – State officials in Arizona have authorized and financed what amounts to the country's initial controlled study of whole psilocybin mushrooms as a treatment for post-traumatic stress disorder (PTSD) among police officers, firefighters, and ...
Bioxyne Reports Record Revenue, Yet Cash Outflows Climb on Expansion Push
SYDNEY – Bioxyne Limited, an Australian life sciences and wellness products company, posted its highest quarterly revenue on record for the period ended September 30, with sales reaching A$14.1 million, a 210% jump from the ...
Kansas Poll Shows Broad Support for Cannabis Reform
TOPEKA – A recent survey of Kansas residents highlights growing public enthusiasm for Cannabis policy changes, with nearly seven in ten adults endorsing medical use and close to six in ten favoring recreational access. A ...
Cybin Raises $175M in Direct Offering, Reinforcing Psychedelic Pipeline
TORONTO – Cybin Inc., a clinical-stage biopharmaceutical company focused on psychedelic-based treatments for mental health disorders, disclosed a $175 million registered direct offering, drawing commitments from a roster of established biotech investors. The deal, priced ...
MariMed Steps Away from Missouri Operations
NORWOOD – In a sharp turn from expansion plans, MariMed Inc. announced it is shutting down its Missouri operations, ending a yearlong effort to build a foothold in the state's burgeoning recreational market and opting ...
Lebanon Legalizes Cannabis, Forms Oversight Body, Targeting $1B in Annual Revenue
BEIRUT – In a significant step forward in leveraging its Cannabis sector for economic relief, the Lebanese government established a dedicated committee to regulate the cultivation and sales of Cannabis under a long-dormant 2020 law. ...
Verano Shareholders Approve Corporate Home Relocation to Nevada
CHICAGO – Verano Holdings Corp. secured strong backing from investors to move its parent company's legal base from British Columbia, Canada, to Nevada. The approval came during a special shareholder meeting, clearing a key hurdle ...
